BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30532069)

  • 1. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
    Nishimura T; Nakata A; Chen X; Nishi K; Meguro-Horike M; Sasaki S; Kita K; Horike SI; Saitoh K; Kato K; Igarashi K; Murayama T; Kohno S; Takahashi C; Mukaida N; Yano S; Soga T; Tojo A; Gotoh N
    Oncogene; 2019 Apr; 38(14):2464-2481. PubMed ID: 30532069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
    Li G; Wu J; Li L; Jiang P
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
    J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.
    Cheung CHY; Hsu CL; Tsuei CY; Kuo TT; Huang CT; Hsu WM; Chung YH; Wu HY; Hsu CC; Huang HC; Juan HF
    Cell Death Dis; 2019 Oct; 10(11):786. PubMed ID: 31624245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
    Yu C; Yang L; Cai M; Zhou F; Xiao S; Li Y; Wan T; Cheng D; Wang L; Zhao C; Huang X
    J Cell Mol Med; 2020 Jan; 24(2):1568-1577. PubMed ID: 31778025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell.
    Wan X; Wang C; Huang Z; Zhou D; Xiang S; Qi Q; Chen X; Arbely E; Liu CY; Du P; Yu W
    Cell Death Dis; 2020 Aug; 11(8):649. PubMed ID: 32811824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.
    Nilsson R; Jain M; Madhusudhan N; Sheppard NG; Strittmatter L; Kampf C; Huang J; Asplund A; Mootha VK
    Nat Commun; 2014; 5():3128. PubMed ID: 24451681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.
    Hitzel J; Lee E; Zhang Y; Bibli SI; Li X; Zukunft S; Pflüger B; Hu J; Schürmann C; Vasconez AE; Oo JA; Kratzer A; Kumar S; Rezende F; Josipovic I; Thomas D; Giral H; Schreiber Y; Geisslinger G; Fork C; Yang X; Sigala F; Romanoski CE; Kroll J; Jo H; Landmesser U; Lusis AJ; Namgaladze D; Fleming I; Leisegang MS; Zhu J; Brandes RP
    Nat Commun; 2018 Jun; 9(1):2292. PubMed ID: 29895827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.
    Liu X; Liu S; Piao C; Zhang Z; Zhang X; Jiang Y; Kong C
    Cancer Sci; 2021 Dec; 112(12):4909-4919. PubMed ID: 34632667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.
    Wang LW; Shen H; Nobre L; Ersing I; Paulo JA; Trudeau S; Wang Z; Smith NA; Ma Y; Reinstadler B; Nomburg J; Sommermann T; Cahir-McFarland E; Gygi SP; Mootha VK; Weekes MP; Gewurz BE
    Cell Metab; 2019 Sep; 30(3):539-555.e11. PubMed ID: 31257153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
    Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
    J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
    Li Q; Yang F; Shi X; Bian S; Shen F; Wu Y; Zhu C; Fu F; Wang J; Zhou J; Chen Y
    FEBS Open Bio; 2021 Oct; 11(10):2845-2857. PubMed ID: 34231329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway.
    Ducker GS; Chen L; Morscher RJ; Ghergurovich JM; Esposito M; Teng X; Kang Y; Rabinowitz JD
    Cell Metab; 2016 Jun; 23(6):1140-1153. PubMed ID: 27211901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
    Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
    Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.
    Tedeschi PM; Vazquez A; Kerrigan JE; Bertino JR
    Mol Cancer Res; 2015 Oct; 13(10):1361-6. PubMed ID: 26101208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
    Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
    J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy.
    Yang C; Zhang J; Liao M; Yang Y; Wang Y; Yuan Y; Ouyang L
    Drug Discov Today; 2021 Mar; 26(3):817-825. PubMed ID: 33316375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
    Nilsson R; Nicolaidou V; Koufaris C
    Gene; 2019 Oct; 716():144032. PubMed ID: 31377316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.
    Green AC; Marttila P; Kiweler N; Chalkiadaki C; Wiita E; Cookson V; Lesur A; Eiden K; Bernardin F; Vallin KSA; Borhade S; Long M; Ghahe EK; Jiménez-Alonso JJ; Jemth AS; Loseva O; Mortusewicz O; Meyers M; Viry E; Johansson AI; Hodek O; Homan E; Bonagas N; Ramos L; Sandberg L; Frödin M; Moussay E; Slipicevic A; Letellier E; Paggetti J; Sørensen CS; Helleday T; Henriksson M; Meiser J
    Nat Metab; 2023 Apr; 5(4):642-659. PubMed ID: 37012496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
    Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
    Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.